![]() Inflazome Inflazome engages in developing orally available drugs to address clinical unmet needs in inflammatory diseases by targeting the inflammasome. | ||
Founding Date | Founding Date 2005 | Founding Date 2016 |
Type | Type Private | Type Subsidiary |
Tags | ||
Locations | Locations Park City, US HQ | Locations Dublin 2, IE HQ Brisbane City, AU Cambridge, GB |
Employees | Employees 525% increase | Employees 156% decrease |
Funding | ||
Total funding raised | Total funding raised $ 90m | Total funding raised $ 17m |

Inflazome engages in developing orally available drugs to address clinical unmet needs in inflammatory diseases by targeting the inflammasome.
View company